Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma

BACKGROUND/AIMS: Several studies have suggested that surgical resection (SR) can provide a survival benefit over transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) at the intermediate stage according to the Barcelona Clinic Liver Cancer (BCLC) staging system. However, the crit...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jun Young, Sinn, Dong Hyun, Gwak, Geum-Youn, Choi, Gyu-Seong, Saleh, Aldosri Meshal, Joh, Jae-Won, Cho, Sung Ki, Shin, Sung Wook, Carriere, Keumhee Chough, Ahn, Joong Hyun, Paik, Yong-Han, Choi, Moon Seok, Lee, Joon Hyeok, Koh, Kwang Cheol, Paik, Seung Woon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946408/
https://www.ncbi.nlm.nih.gov/pubmed/27377909
http://dx.doi.org/10.3350/cmh.2016.0015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946408/
https://www.ncbi.nlm.nih.gov/pubmed/27377909
http://dx.doi.org/10.3350/cmh.2016.0015

Ejemplares similares